We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Characteristics and mechanisms of latency-reversing agents in the activation of the human immunodeficiency virus 1 reservoir

    The "Shock and Kill" method is being considered as a potential treatment for eradicating HIV-1 and achieving a functional cure for acquired...

    Zhujiao Zhou, Yashuang Jiang, ... Geng Yang in Archives of Virology
    Article 29 November 2023
  2. Epstein-Barr virus variation in people living with human immunodeficiency virus in southeastern China

    Background

    Patients infected with HIV are at high risk of develo** Epstein-Barr Virus (EBV)-related diseases. The genotype and viral biological...

    Zhikai Wan, Ying Chen, ... Biao Zhu in Virology Journal
    Article Open access 31 May 2023
  3. The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)

    Background

    Viroporins are virally encoded ion channels involved in virus assembly and release. Human immunodeficiency virus type 1 (HIV-1) and...

    Wyatt Henke, Hope Waisner, ... Edward Stephens in Retrovirology
    Article Open access 19 November 2022
  4. Association of TREX1 polymorphism with disease progression in human immunodeficiency virus type-1 (HIV-1) infected patients

    The time interval between HIV-1 infection and AIDS development is not the same in all patients and depends largely on the genetic background of the...

    Nastaran Tohidi, Seyed Ali Dehghan Manshadi, Mahboubeh Hajiabdolbaghi in Virus Genes
    Article 20 September 2023
  5. HIV

    Acquired immunodeficiency syndrome (AIDS) is a life-threatening chronic condition caused by the human immunodeficiency virus (HIV). HIV infection...
    Stefano Buttò, Elena Vittoria Longhi in Managing Psychosexual Consequences in Chronic Diseases
    Chapter 2023
  6. Human Immunodeficiency Virus as a Risk Factor for Cardiovascular Disease

    The developments in HIV treatments have increased the life expectancy of people living with HIV (PLWH), a situation that makes cardiovascular disease...

    Agnieszka Lembas, Andrzej Załęski, ... Alicja Wiercińska-Drapało in Cardiovascular Toxicology
    Article Open access 20 November 2023
  7. Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 years

    Viruses are naturally endowed with the capacity to transfer genetic material between cells. Following early skepticism, engineered viruses have been...

    Jonas Holst Wolff, Jacob Giehm Mikkelsen in Journal of Biomedical Science
    Article Open access 09 October 2022
  8. Predictors of hippocampal tauopathy in people with and at risk for human immunodeficiency virus infection

    Combination antiretroviral therapy (cART) has extended lifespans of people living with HIV (PWH), increasing both the risk for age-related...

    Sophie Nader, Esma Karlovich, ... Susan Morgello in Journal of NeuroVirology
    Article 05 November 2023
  9. Exploring the biological function of immune cell-related genes in human immunodeficiency virus (HIV)-1 infection based on weighted gene co-expression network analysis (WGCNA)

    Background

    Acquired immunodeficiency syndrome (AIDS) is a chronic infectious disease characterized by consistent immune dysfunction. The objective of...

    Ruo**g Bai, Zhen Li, ... Hao Wu in BMC Medical Genomics
    Article Open access 19 September 2022
  10. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda

    Background

    Women living with HIV are at risk for cervical dysplasia and cancer worldwide. In 2015, the World Health Organization (WHO) recommended...

    Harriet Nakigozi, Rawlance Ndejjo, ... Susan Nabadda in BMC Cancer
    Article Open access 21 February 2024
  11. Advances in HIV therapeutics and cure strategies: findings obtained through non-human primate studies

    Human immunodeficiency virus (HIV), the main contributor of the ongoing AIDS epidemic, remains one of the most challenging and complex viruses to...

    Alison R. Van Zandt, Andrew G. MacLean in Journal of NeuroVirology
    Article 27 August 2023
  12. Molecular identification and genetic characteristics of Cryptosporidium spp., Giardia duodenalis, and Enterocytozoon bieneusi in human immunodeficiency virus/acquired immunodeficiency syndrome patients in Shanghai, China

    Background

    Opportunistic infections are a ubiquitous complication in human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)...

    Yanyan Jiang, Li Liu, ... Yujuan Shen in Parasites & Vectors
    Article Open access 04 February 2023
  13. Neuroinflammation driven by human immunodeficiency virus-1 (HIV-1) directs the expression of long noncoding RNA RP11-677M14.2 resulting in dysregulation of neurogranin in vivo and in vitro

    Neuroinflammation and synaptodendritic damage represent the pathological hallmarks of HIV-1 associated cognitive disorders (HAND). The post-synaptic...

    Roberta S. dos Reis, Marc C. E. Wagner, ... Velpandi Ayyavoo in Journal of Neuroinflammation
    Article Open access 24 April 2024
  14. Anti-human immunodeficiency virus-1 activity of MoMo30 protein isolated from the traditional African medicinal plant Momordica balsamina

    Background

    Plants are used in traditional healing practices of many cultures worldwide. Momordica balsamina is a plant commonly used by traditional...

    Mahfuz Khan, Amad Diop, ... Michael D. Powell in Virology Journal
    Article Open access 22 March 2023
  15. Immunodeficiency Diseases

    Immunodeficiency disorders are conditions where the defence mechanism of the body is impaired. They show enhanced susceptibility to infection with...
    Subhash Chandra Parija in Textbook of Microbiology and Immunology
    Chapter 2023
  16. Structural Insights to Human Immunodeficiency Virus (HIV-1) Targets and Their Inhibition

    Human immunodeficiency virus (HIV) is a deadly virus that attacks the body’s immune system, subsequently leading to AIDS (acquired immunodeficiency...
    Murugesan Vanangamudi, Pramod C. Nair, ... Vigneshwaran Namasivayam in Antiviral Drug Discovery and Development
    Chapter 2021
  17. New Antiretroviral Agents for HIV Infection

    The development of antiretroviral drugs for treatment of human immunodeficiency virus (HIV) infection is the most remarkable achievement in medical...
    Chapter 2023
  18. Highly mutated monoclonal antibody 3F2 targets a conformational and strain-restricted epitope in human immunodeficiency virus gp41 with significant antibody-dependent cell cytotoxicity

    Identifying epitope targets by studying the native antibody (Ab) response can identify potential novel vaccine constructs. Studies suggest that...

    Devin DeCotes, Sarah Baron, ... Mark D. Hicar in Archives of Virology
    Article 24 July 2022
  19. Biodistribution and immunity of adenovirus 5/35 and modified vaccinia Ankara vector vaccines against human immunodeficiency virus 1 clade C

    Previously, we developed a chimeric adenovirus type 5 with type 35 fiber (Ad5/35), which has high tropism to dendritic cells and low hepatoxicity....

    Masaru Shimada, Haibin Wang, ... Kenji Okuda in Gene Therapy
    Article 06 January 2022
Did you find what you were looking for? Share feedback.